BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $12.89 million. The enterprise value is -$4.31 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 226.96% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +226.96% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 1.52% |
| Float | 7.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.10, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.10 |
| Quick Ratio | 8.64 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -54.30 |
Financial Efficiency
Return on equity (ROE) is -101.64% and return on invested capital (ROIC) is -55.11%.
| Return on Equity (ROE) | -101.64% |
| Return on Assets (ROA) | -48.28% |
| Return on Invested Capital (ROIC) | -55.11% |
| Return on Capital Employed (ROCE) | -93.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.83% in the last 52 weeks. The beta is 0.53, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -93.83% |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 8.27 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 138,369 |
Short Selling Information
The latest short interest is 160,521, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 160,521 |
| Short Previous Month | 150,494 |
| Short % of Shares Out | 2.13% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.07M |
| Pretax Income | -17.54M |
| Net Income | -17.91M |
| EBITDA | -17.84M |
| EBIT | -18.07M |
| Earnings Per Share (EPS) | -$12.12 |
Full Income StatementBalance Sheet
The company has $17.54 million in cash and $349,894 in debt, giving a net cash position of $17.19 million or $2.28 per share.
| Cash & Cash Equivalents | 17.54M |
| Total Debt | 349,894 |
| Net Cash | 17.19M |
| Net Cash Per Share | $2.28 |
| Equity (Book Value) | 19.01M |
| Book Value Per Share | 9.93 |
| Working Capital | 18.42M |
Full Balance SheetCash Flow
| Operating Cash Flow | -19.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
